Prajwal Boddu - Concepedia

Author

Prajwal Boddu

The University of Texas MD Anderson Cancer Center

Also Known As

Bar-Natan, Michal, P Boddu, Prajwal Boddu, Prajwal C Boddu, Prajwal C. Boddu, Prajwal Chaitanya Boddu

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Kuwait Cancer Control Center Yale University The University of Texas Health Science Center at Houston National Cancer Institute

About

Prajwal Boddu is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, hematology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	295
2	Health Sciences	4	4	146
3	Cell Biology	2	2	71
4	Blood Transplantation	1	1	20
5	Classical Hematology	1	1	20

Prajwal Boddu

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study Naval Daver, Guillermo Garcia‐Manero, Sreyashi Basu, Cancer Discovery	2018	559
Clinical and pathological characteristics of HIV- and HHV-8–negative Castleman disease Li Yu, Meifeng Tu, Jörge E. Cortes, Blood	2017	171
Gut Microbiome Signatures Are Predictive of Infectious Risk Following Induction Therapy for Acute Myeloid Leukemia Jessica Galloway-Peña, Yushu Shi, Christine B. Peterson, Clinical Infectious Diseases	2019	124
Analysis of cardiovascular and arteriothrombotic adverse events in chronic-phase CML patients after frontline TKIs Preetesh Jain, Hagop M. Kantarjian, Prajwal Boddu, Blood Advances	2019	121
Treated secondary acute myeloid leukemia: a distinct high-risk subset of AML with adverse prognosis Prajwal Boddu, Hagop M. Kantarjian, Guillermo Garcia‐Manero, Blood Advances	2017	108
Co-occurrence of FLT3-TKD and NPM1 mutations defines a highly favorable prognostic AML group Prajwal Boddu, Hagop M. Kantarjian, Gautam Borthakur, Blood Advances	2017	77
Validation of the 2017 European LeukemiaNet classification for acute myeloid leukemia with <i>NPM1</i> and <i>FLT3</i> ‐internal tandem duplication genotypes Prajwal Boddu, Tapan M. Kadia, Guillermo Garcia‐Manero, Cancer	2018	60
Characteristics and outcomes of older patients with secondary acute myeloid leukemia according to treatment approach Prajwal Boddu, Hagop M. Kantarjian, Farhad Ravandi, Cancer	2017	59
Prognostic significance of additional chromosomal abnormalities at the time of diagnosis in patients with chronic myeloid leukemia treated with frontline tyrosine kinase inhibitors Ahmad Alhuraiji, Hagop M. Kantarjian, Prajwal Boddu, American Journal of Hematology Hematological MalignancyChronic Myeloid LeukemiaMedicineMixed-phenotype Acute LeukemiaMalignant Blood Disorder	2017	49
Patient characteristics and outcomes in adolescents and young adults with classical Philadelphia chromosome-negative myeloproliferative neoplasms Prajwal Boddu, Lucia Masárová, Srđan Verstovšek, Annals of Hematology Hematological MalignancyYoung AdultsMedicineHematologyMyeloid Neoplasia	2017	44

Page 1